Condition
Durvalumab
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 6 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
6 shownHepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)NCT06859684 · 2025-03-01
RECRUITINGLow-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLCNCT05092412 · 2022-03-02
ACTIVE_NOT_RECRUITINGAn Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in ChineseNCT05245994 · 2021-08-21
UNKNOWNProspective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With DurvalumabNCT05027165 · 2020-11-07
UNKNOWNEfficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal MetastasisNCT04356222 · 2020-06-01
UNKNOWNAnlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm StudyNCT04314297 · 2020-04-01
UNKNOWNCommon interventions
DurvalumabDRUG3Anlotinib In Combination With DurvalumabDRUG1Durvalumab, etoposide, and cisplatin/carboplatin followed by durvalumab and olaparibDRUG1Etoposide, and cisplatin/carboplatinDRUG1hepatic arterial infusion chemotherapy (HAIC)DRUG1LenvatinibDRUG1Low-dose radiotherapyRADIATION1methotrexateDRUG1Non-interventionalOTHER1
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Trial status mix
UNKNOWN4
ACTIVE_NOT_RECRUITING1
RECRUITING1
Phase mix
PHASE24
PHASE41
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.